Ruxolitinib
Ruxolitinib is a potent and selective JAK1/2 inhibitor (IC50: 3.3/2.8 nM) and is relatively less selective for JAK3 (IC50: 322 nM).
| Catalog Number | T1829 |
| Alternative Name(s) | INCB018424 , (R)-Ruxolitinib |
| Research Area | Autophagy|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors|||Stem Cells|||Chromatin/Epigenetic|||Angiogenesis|||Apoptosis |
| Molecular Formula | C17H18N6 |
| CAS# | 941678-49-5 |
| Purity | 99.40% |
| SMILES | N#CC[C@H](C1CCCC1)n1cc(cn1)-c1ncnc2[nH]ccc12 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Ruxolitinib |
| Additional Information | https://www.targetmol.com/datasheet/T1829 |